Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - ACCOUNTS PAYABLE
Accounts Payable DMAC - DiaMedica Therapeutics Inc.
926 K
LAST VALUE
34.88%
2 YEAR CAGR
13.90%
5 YEAR CAGR
9.55%
10 YEAR CAGR